You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Consolidation

Showing 26 - 50 of 2,846
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Liver Cell Carcinoma
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)

Recruiting
  • Locally Advanced Non-small Cell Lung Cancer
  • Efficacy and Safety
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 28, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 12, 2022

Cancer Patients Receiving Stereotactic Body RTX Trial in Dallas (SBRT)

Recruiting
  • Cancer Patients Receiving Stereotactic Body RTX
  • SBRT
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Aug 25, 2022

Sleep and Motor Learning in Stroke

Recruiting
  • Stroke
    • Oxford, United Kingdom
      Wellcome Centre for Integrative Neuroimaging (WIN)
    Mar 6, 2023

    Head and Neck Tumors Trial in Detroit (Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA])

    Recruiting
    • Head and Neck Neoplasms
    • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
    • Detroit, Michigan
      Henry Ford Health System
    Dec 19, 2022

    Speech, Consolidation Trial in Montréal (Adaptation, cTBS)

    Recruiting
    • Speech
    • Consolidation
    • Adaptation
    • cTBS
    • MontrĂ©al, Quebec, Canada
      McGill Univeristy
    May 17, 2022

    NSCLC Trial in Philadelphia (Pembrolizumab)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 1, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

    Recruiting
    • B Cell Lymphoma
    • +5 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 3, 2023

    Gallbladder Cancer Unresectable Trial in Lucknow (chemoradiation)

    Recruiting
    • Gallbladder Cancer Unresectable
    • chemoradiation
    • Lucknow, Uttar Pradesh, India
      Sanjay Gandhi Postgraduate Institute of Medical Sciences
    Aug 6, 2022

    Rectal Cancer Trial in Santiago (drug, radiation, behavioral, procedure)

    Recruiting
    • Rectal Cancer
    • Santiago, RM, Chile
    • +2 more
    Oct 24, 2022

    NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • primary tumour radiotherapy
    • +2 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

    Not yet recruiting
    • Lymphoblastic Leukemia in Children
    • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
    • +7 more
    • (no location specified)
    Oct 24, 2023

    Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))

    Not yet recruiting
    • Limited Stage Small Cell Lung Cancer
    • (no location specified)
    Jun 29, 2022

    Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)

    Recruiting
    • Limited Stage Small Cell Lung Cancer
    • Shanghai, Shanghai, China
    • +1 more
    Jul 29, 2022

    Large B-cell Lymphoma, Lymphoma Trial in Houston (Loncastuximab Tesirine)

    Not yet recruiting
    • Large B-cell Lymphoma
    • Lymphoma
    • Loncastuximab Tesirine
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 14, 2022

    FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

    Available
    • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
    • (no location specified)
    Oct 18, 2022

    Acute Myeloid Leukemia Trial in Minsk (Expanded haploidentical NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • Expanded haploidentical NK cells
    • Minsk, Minsk Region, Belarus
      Belarussian Research Center for Pediatric Oncology, Hematology a
    Apr 12, 2022

    Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
    • (no location specified)
    Jun 7, 2022

    Lung Cancer, Wedge Resection, Ground-glass Opacity Trial in Shanghai (Wedge resection)

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • Wedge resection
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 25, 2023

    Consolidation of Abstract Information During Sleep Trial in Philadelphia (Congruent vs. Incongruent, Immediate vs. Awake vs.

    Recruiting
    • Consolidation of Abstract Information During Sleep
    • Congruent vs. Incongruent
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Feb 14, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, gemcitabin, cisplatin, Stereotactic Body Radiotherapy, Intensity

    Recruiting
    • Nasopharyngeal Carcinoma
    • Camrelizumab, gemcitabin, cisplatin
    • Stereotactic Body Radiotherapy, Intensity modulated-radiotherapy
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Jun 19, 2022

    Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

    Not yet recruiting
    • Multiple Myeloma
    • Dara-VRd intensification, Dara-R maintenance
    • +4 more
    • (no location specified)
    Dec 13, 2022